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INTRODUCTION
Natural treatment for lupus nephritis is a very potent 
and challenging on drug development. A large number 
of medicinal plants have beneficial effects which can 
be used in lupus nephritis treatment, such as immu-
nosuppressant, antioxidant, anti-inflammatory, and 
antidepressant. These plants have not been explored 
clearly on lupus condition.1,2,3 Some Chinese Herbal 
Medicine, Ayurveda, and Traditional Kampo treatment 
which were used for treating lupus have been studied 
for its efficacy. However, some of the traditional medi-
cines have side effects on liver enzyme abnormality.4 
Therefore, we investigated a lupus candidate drug from 
a medicinal plant which has a hepatoprotective activity5,6 
and also known as a nontoxic material, Kalanchoe 
pinnata (Lmk) Pers leaves (KP). 
Polar compounds in aqueous extract of KP has beneficial 
effects for lupus condition. The activities include anti-
convulsant,2 anti-nociceptive and anti-inflammatory,7,8 
immunosuppressant,9,10 and T cell suppression.11 It 
also has a relaxant uterus effect so that it is safe for 
maternity.12,13 fenoterol, in human myometrium. KP is 
also a safe material proved by using an accurate acute 
and subchronic toxicity test.14 Compounds found KP 
are quercetin glycosyl conjugates, rutin, stigmasterol, 
3,8-dimethoxy-4,5,7-trihydroxyflavone, friedelin, 
epigallocatechin-3-o-syringate, luteolin, kaempferol, 
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quercetin,15,16 quercetin-3L-rhamnosido-L-arabino 
furanoside, quercetin-3-O-diarabinoside, kaemp-
ferol-3 glucoside, bryophollone, bryophyllin A, 
Bryophyllin C, bersaldegenin-3-acetate, bersalde-
genin-1,3,5-orthoacetate, daigremontianin.17,18 
KP has many beneficial effects and safety profiles, so 
it is appropriate to be developed as a new drug 
candidate for lupus nephritis. Therefore, this research 
determined the efficacy of the KP extract used in a 
lupus model. A well-known lupus model, Pristane-
induced lupus, was used based on its broad severe 
lupus nephritis manifestations.3,19,20 The efficacy of 
the KP comes from multiple compounds, but we can 
predict the active compounds on lupus responsible 
receptors, such as glucocorticoid. Moreover, this 
research focused on the effect of aqueous extract of 
KP on repairing the lupus nephritis manifestations 
and the potential active compounds involved. 
MATERIALS AND METHODS
MATERIALS
The Kalanchoe pinnata (Lmk) Pers fresh leaves (KP) 
were collected from Manoko, Bandung. All of the 
leaves below the fourth top leaves were used. The 
plant identification was confirmed at the Herbarium 
Bandungense, Bandung Institute of Technology.
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Pristane® which contains 2,6,10,14 tetramethylpentadecane (TMPD) 
≥98% was purchased from Sigma-Aldrich.
Female Balb/c mice aged seven weeks were purchased from LPPT UGM. 
Mice were housed under specific conditions. They were fed by using 
standard diet and water ad-libitum. We also use reagent strips for urine 
analysis (Verify®) to check the level total protein in the urine of each 
mouse tested. 
METHODS
Preparation of the extract
Aqueous extract of KP leaves was processed from pressed fresh leaves. 
The extract was dried by using freeze dryer equipment (Eyela). The KP 
extract profile was measured by using UPLC-QTOF-MS/MS tandem 
instrument (Waters) by using Acquity UPLC column BEH C18 1.7µm 
2.1×50 mm, flow rate 0.3 ml/minute. The injected volume was 5µl 
(the concentration of 5000 µg/L). The temperature used was 40oC. Also, 
the eluent used was A: H2O+formic acid 0.1%, B: acetonitrile + formic 
acid 0.1%. 
Experimental grouping
An animal model for lupus used was Pristane-treated mice. Female 
Balb/c mice were injected by using 0.5 mL Pristane intraperitoneally, 
and then the booster injection was done at the day 90th.10 Proteinuria 
level was measured at 5th month after the induction and then lasted until 
the severe sign detected at month 8th. All of the induced mice experi-
enced proteinuria at the level of ++ (100 mg/dL). The mice were grouped 
into some treatment groups (n=8 per group). Three treatment groups 
received the aqueous extract of KP at the doses of 200, 400, and 600 mg/kg 
body weight. There also positive control mice which received prednisone 
at a dose of 25 mg/kg body weight. The other groups were a preventive 
group that received extract at doses 200 mg/kg body weight and the 
standard group that did not induce by using Pristane.
Treatment
The KP extract was given orally to the treatment groups for 21 days. Protein 
level in the urine of all groups was measured every seven days. At the day 
21st, mice were sacrificed then the renal histology observation was done 
by using Haematoxylin-Eosin (HE) staining. The data was analyzed by 
using Oneway ANOVA. This protocol was approved by the local ICUC 
of Faculty of Veterinary Medicine, Universitas Airlangga, Indonesia, 
with the number of 512-KE.
Docking analysis to predict the potentially active 
compounds
The in silico study was performed by using glucocorticoid receptor (Gene-
Bank) and the chemical structures of some flavonoid compounds in KP, 
and also the prednisone chemical structure (PubChem). The structures 
were stabilized by using Chem3D Program, and then the docking was 
performed by using Molegro Virtual Docker. All of the programs used 
were licensed programs of Universitas Airlangga. 
RESULTS 
Characteristics of the aqueous extract of Kalanchoe 
pinnata (Lmk) Pers (KP)
The yield of the extract was 1.95%w/w. Based on the organoleptic obser-
vation, the extract was dark yellow hygroscopic crystals resembling light 
materials. It was kept in the freezer until it was used. The identity profile 
of aqueous extract used was provided as a chromatogram profile (Figure 1) 
obtained using UPLC-QTOF-MS/MS tandem system. 
The main compound was at the retention time of 2.79 and was predicted 
as flavonoid compounds. A lot of literature mention the name of specific 
flavonoid compounds found in this plant. This data supported by a 
phytochemical screening data that show the presence of flavonoids, sapo-
nin, tannin, and steroid/triterpenoid. Besides, the physical characteristics 
of the KP extract including water content 9.00% v/w, compounds soluble 
in water 54.34% w/w, and compounds soluble in ethanol 3.57% w/w. The 
characteristics exhibit beneficial and stable features of a solid material. 
Three compounds in aqueous extract of KP has been widely studied. 
A lot of chemical compounds were found, such as steroids, terpenoids, 
flavonoids, phenolic, tannin, alkaloids, glycosides, carbohydrates, and 
proteins. The aqueous extract contains carbohydrates, proteins, flavonoids, 
phenolic, tannins, and glycosides. The leaves contain astragalin, 
3,8-dimethoxy-4,5,7-trihydroxyflavone, friedelin, epigallocatechin-3-o-
syringate, luteolin, rutin, kaempferol, quercetin, quercetin-3L-rhamno-
sido-L-arabino furanoside, quercetin-3-O-diarabinoside, and kaemp-
ferol-3-glucoside.16,21 These multiple compounds might have the synergic 
effects that reduce lupus nephritis manifestations. 
The effects of aqueous extract of Kalanchoe pinnata 
(Lmk) Pers leaves on lupus nephritis mice
The mice received a daily dose of aqueous extract of KP during 21 days. 
The protein level of the urine of the treated mice groups was decreased 
(Table 1). Proteinuria is a parameter for severity of nephritis.22,23 (-/- 
Moreover, there was no severe proteinuria obtained on the mice until the 
6th month after the induction. The mice only had mild proteinuria + (30 
mg/dL) which revealed the low disease progress. This result was biased 
because the normal mice could reach proteinuria at the same level.
Then, the induction time was continued with a strict observation of 
proteinuria every seven days. As a result, the mice had proteinuria ++ 
(100 mg/dL) on the month 8th. Thus, they were ready for experimental 
grouping.
After the treatment period, the trend of proteinuria level decreased from 
level ++ (100 mg/dL) to level + (30 mg/dL) except the negative control 
groups. On the treatment groups, the dose of 200 mg/kgBW was the one 
that more active to decrease proteinuria level. The result was not as stable 
as the prednisone effect. On the preventive group, the proteinuria did not 
increase although they were injected twice using Pristane. Their physical 
condition showed a healthy behavior.
Proteinuria level was not the primary parameter to measure the severity 
of nephritis. Therefore, the observation was conducted in renal histology 
observation. Haematoxylin-Eosin (HE) staining showed the differences 
of each treatment effect on renal tissue structure. The results were in 
Figure 2.
The normal renal tissue of normal mice (Figure 2a) indicated by the 
mesangial area (long black arrow) seems thin with a regular structure, 
Figure 1: The profile of chemical compounds in aqueous extract of 
Kalanchoe pinnata (Lmk) Pers. Leaves.
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and then the glomerulus (big circle) present between urinary spaces of 
Bowman’s capsule. The glomerulus is a plaited mat of the capillary that 
has a filtration function. There is no proliferation of erythrocytes and 
inflammation cells inside the glomerulus (little circle). The area marked 
by green arrow is a position of glomerular basement membrane (GBM) 
that is thin in a healthy condition. 
Furthermore, the positive control which only receiving placebo (Figure 2b) 
had many structural changes, such as the GBM is thicker than usual with 
a proliferation of glomerulus results in inflammation. This condition has 
been reported before.10 Then, the glomerulus attaches the Bowman’s 
capsule area, so the spaces are closed. In this situation, the filtration func-
tion performed difficultly. Besides, the mesangial area is thickened, are 
irregularly structured, and the cytoplasm cells are accumulated.
In the treatment group at the dose of 200 mg/kgBW (Figure 2c), the 
inflamed glomerulus was decreased. But, the GBM still looked thick. The 
cells accumulation is slightly reduced in the glomerulus. The mesangial 
area was shown the same structure with the Figure 2b. On the other 
groups received the extract at the dose of 400 and 600 mg/kgBW (Figure 2 d 
and e), the anti-inflammatory effect still present. The urinary spaces 
in Bowman’s capsule looked wider although not achieve the healthy 
appearance. The mesangial area looked more regularly structured by the 
increase of the dose. The GBM thickness seemed similar to the low treat-
ment dose, but it needs further measurement. 
On the standard group received prednisone (Figure 2f), the accumula-
tion of cells in the glomerulus and the glomerular inflammation were 
decreased although the GBM is still dense. The mesangial area looked 
thick, and not all of the area showed the repairing of the structure. At 
the last group, the preventive group, the histology structure is similar to 
the healthy mice.
The histology observation results show the repairing effect of aqueous 
extract of KP on many parts, such as tubules, glomerulus, GBM, and the 
Bowman’s Capsule space. The treatment groups showed the alteration 
that it reduces the inflammation. The modification is not as good as the 
preventive group, but the effect is very potential to maintain the lupus 
patient stability. 
Autoantigen-antibody complexes caused inflammation that occurred in 
glomerulus.20,24 One of the autoantigens was nucleosome. Nucleosomes 
and anti-nucleosome antibodies have been shown to bind to the glomer-
ular basal membrane (GBM). It is assumed that nucleosomes bind to the 
GBM via their histone proteins. The glomerulonephritis was developed 
by the formation of nucleosome-containing immune complexes. Also, 
there may be cross-reactivity of nucleosome-specific antibodies (e.g., 
with heparan sulfate or a so-far-unknown surface antigen) whereby 
these autoantibodies reach the glomeruli and cause inflammation.25,26
Figure 2 : Morphology of renal tissue at the magnitude of 400x by us-
ing light micrographs of a renal glomerulus of all groups Where; normal 
mouse of (a), negative control (b), treatment at the dose of 200 mg/kg 
BW (c), treatment at the dose of 400 mg/kg BW (d), treatment at the 
dose of 600 mg/kg BW (e), prednisone at the dose of 25 mg/kg BW (f ), 
and preventive group (g). n= 8 mice per group.
Table 1: Proteinuria Level Before And After Kp Extract Treatment.
Group Protein level in the urine (mg/dL)
Before treatment After treatment
Treatment group at a dose of 200 mg/kg BW KP 200.00±115.47  65.00±40.41*
Treatment group at a dose of 400 mg/kg BW KP  65.00±40.41  22.50±8.66*
Treatment group at a dose of 600 mg/kg BW KP 112.00±110.77  55.00±41.53*
Prednisone at a dose of 25 mg/kgBW 200.00±115.47  30.00±0.00*
Negative control that received placebo  82.50± 35.00 132.50±116.44
Preventive group (treatment during induction time)  15.00±0.00  18.75±7.50*
* Different significantly compared to the negative control group with p<0.05. n = 8 mice per group using t-test Statistics
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This result showed a capability of aqueous extract of KP in reducing 
the inflammation of glomerulus in the lupus nephritis mice model. It 
also prevents the mice from Pristane induction effect, so the mice keep 
normal although they received the second injection. The result showed 
a curative and preventive potency. But, further investigation needed to 
ensure this effect. These data indicate that aqueous extract of KP was 
useful to maintain immune system in lupus nephritis condition. This 
efficacy data is supported by the toxicity data reported by Ozolua14 stating 
that there was no toxicity occurred in acute and subchronic toxicity test. 
Because of the efficacy and the safety, aqueous extract of KP could be a 
good candidate for a natural treatment for lupus nephritis.
The docking of some compounds in KP in glucocorticoid 
receptor
The docking result did not show a correlation with cell culture test, the 
effect on the animal model or others. Docking did not calculate the 
bioavailability, toxicity, and other factors in the body. The main reason 
for the use of docking is to predict the compound which binds to a specific 
receptor (protein) well. We also could see how is the three dimensions 
geometric structure of a compound bound to the active site of the protein.
In this research, we focused on three compounds found in KP, i.e., bryo-
phyllin A, beta-sitosterol, and kaempferol-3-glucoside. The receptor was 
glucocorticoid receptor. This receptor has a very crucial role in immune 
homeostasis. The receptor is shown as a free water receptor. The ligand 
would be shed before the tested compound was inserted into the ligand 
space. 
The compounds tested were prepared as 3D structures with an optimum 
geometric stability, using the Chem3D program. Then, the docking 
results are shown in Figure 3. 
The ligand binding of bryophyllin A to glucocorticoid receptor presents 
through a hydrogen bond with amino acid residue Arg 611 (Figure 3). 
There is also a hydrophobic bonding with Gln 570, Leu 563, Met 560, Ile 
747, Thr 739, Phe 749, Glu 748, Thr 561, Asn 564, and Phe 623. Figure 
3b shows beta-sitosterol binds the receptor with hydrogen bonds to Arg 
611 and Gln 570, and also hydrophobic bonds with Gln 738, Try 735, Phe 
737, Leu 741, Thr 739. Ile 757, Phe 740, Cys 736, Met 601, Phe 749, Leu 
753, Trp 600, Asn 564 and Leu 563. Fig. 5Sc showed that kaempferol-
3-glucoside binds into glucocorticoid receptor using hydrogen bonds 
with Arg 611 and Asn 564, and hydrophobic bonds with Tyr 735, Leu 
732, Cys 736, Phe 749, Met 639, Gln 642, Met 560, Met 646, Phe 623, Gln 
570, and Met 604. 
According to the scoring calculation, the free binding energy of bryophylin 
A compound is -66.6975 kcal/mol, beta sitosterol is -106.1340 kcal/mol, 
and the kaempferol-3-glucoside is -105.5710 kcal/mol. The results show 
the lowest free binding energy was on bryophyllin A compound. This 
little power makes it easy to bind to the glucocorticoid receptor, so the 
anti-inflammatory effect occurs selectively. At last, the in silico prediction 
of the most active compound results in the bryophyllin A as the com-
pound which has the lowest free binding energy in the glucocorticoid 
receptor. The experiment needs to be conducted using other receptors 
responsible for the lupus pathogenesis to support this result.
DISCUSSION
Aqueous extract of KP is sufficient to reduce inflammatory signs on 
kidney parameters of lupus nephritis mice. This anti-inflammatory 
effect reduces the high pro-inflammatory cytokines released when the 
glomerular inflamed due to the increasing number of immune com-
plexes deposited inside. Flavonoid compounds in the KP have a high 
anti-inflammatory effect and also anti-oxidative results7,27,28,29 which support 
the regulation of immune responses. Lupus marked with irregular 
immune reactions which released suddenly if the triggering factors 
come.30,31 The KP treatment in all doses gives many beneficial outcomes 
in the kidney to reduce and inhibit the glomerular swelling. It followed 
by the lower proteinuria level. Both results show that the glomerulus 
moves to its normal condition. 
The glomerulus disorder in lupus is different with the kidney failure 
signs, which cannot be repaired. Glomerulonephritis in lupus occurred 
as a result of complex immune deposit.32,33 It is possible for the immune 
complex to split and then eliminated from glomerulus, so the glomerulus 
function repaired. 
In this research, all doses tested result in good outcomes to repair the 
kidney structure and function (Figure 2 and Table 1). It leads a further 
question regarding the active compound which responsible for the effect. 
According to the profile of the aqueous extract of KP, the primary 
compounds are flavonoid compounds. Therefore, we challenged some 
active compounds which potentially have an anti-inflammatory effect, 
i.e., bryophyllin A, beta-sitosterol, and kaempferol-3-glucoside. The 
compounds have good affinity to bind the glucocorticoid receptor, a 
receptor involved in the inflammatory process. The glucocorticoid 
receptor is a specific target for anti-inflammatory drugs. The compound 
which has the lowest binding energy to the glucocorticoid receptor was 
bryophyllin A (Figure 3). It means that bryophyllin A can efficiently bind 
the target site in glucocorticoid and results in the highest anti-inflamma-
tory effect. However, the further research to calculate the concentration 
of bryophyllin A in the KP is necessary.
CONCLUSION
The aqueous extract of Kalanchoe pinnata (Lmk) Pers repairs on the 
kidney damage of Pristane-induced lupus nephritis mice. The potential 
flavonoid active compound which could be its active anti-inflammatory 
marker in this result is bryophyllin A.
ABBREVIATIONS USED
KP: Kalanchoe pinnata; TMPD: 2, 6, 10, 14-tetramethylpentadecane; 
GBM: glomerular basement membrane.
Figure 3: The Docking Result of Bryophyllin A (a), Beta-Sitosterol (b) 
and Kaempferol-3-glucoside (c) in the Glucocorticoid Receptor Tested 
Using Molegro Virtual Docker Program.
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SUMMARY
Drug development for advance safe lupus therapy is highly needed. The 
aqueous extract of Kalanchoe pinnata (Lmk) Pers (KP) fresh leaves has 
the activity to reduce lupus manifestation in the kidney of lupus mice. It 
reduces the glomerular inflammation, so the level of protein present in 
the urine can be decreased. Furthermore, the aqueous extract of KP has 
multiple compounds. The most potent compound of this material which 
can bind the glucocorticoid receptor efficiently is the structure of Bryo-
plyllin A, based on the in silico measurement.
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